Alimera Sciences, Inc.
NASDAQ:ALIM
5.54 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 80.754 | 54.129 | 59.029 | 50.82 | 53.943 | 46.97 | 35.912 | 34.333 | 22.438 | 8.423 | 1.872 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 19.584 | 7.977 | 7.03 | 6.941 | 6.626 | 4.679 | 3.438 | 2.344 | 1.762 | 1.442 | 1.863 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 61.17 | 46.152 | 51.999 | 43.879 | 47.317 | 42.291 | 32.474 | 31.989 | 20.676 | 6.981 | 0.009 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.757 | 0.853 | 0.881 | 0.863 | 0.877 | 0.9 | 0.904 | 0.932 | 0.921 | 0.829 | 0.005 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 16.626 | 16.228 | 13.778 | 9.668 | 10.992 | 11.274 | 12.844 | 12.375 | 14.84 | 11.811 | 8.429 | 7.935 | 7.1 | 12.581 | 15.057 | 43.764 | 8.363 | 6.736 |
| General & Administrative Expenses
| 18.53 | 12.871 | 12.774 | 11.652 | 13.954 | 14.525 | 13.039 | 15.263 | 14.19 | 12.371 | 9.613 | 6.575 | 6.203 | 4.61 | 3.407 | 5.058 | 3.184 | 3.028 |
| Selling & Marketing Expenses
| 27.946 | 25.987 | 23.069 | 20.384 | 25.004 | 23.517 | 23.21 | 29.431 | 28.09 | 15.087 | 16.371 | 7.529 | 8.104 | 4.88 | 0.752 | 1.259 | 0.969 | 0.616 |
| SG&A
| 46.015 | 38.858 | 35.843 | 32.036 | 38.958 | 38.042 | 36.249 | 44.694 | 42.28 | 27.458 | 25.984 | 14.104 | 14.307 | 9.49 | 4.159 | 6.317 | 4.153 | 3.644 |
| Other Expenses
| 0 | 2.706 | 2.579 | 2.676 | 2.641 | 2.645 | 2.684 | 2.767 | 2.555 | 0.659 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 62.641 | 57.792 | 52.2 | 44.38 | 52.591 | 51.961 | 51.777 | 59.836 | 59.675 | 39.928 | 34.413 | 22.039 | 21.407 | 22.071 | 19.216 | 50.081 | 12.516 | 10.38 |
| Operating Income
| -1.471 | -11.64 | -0.201 | -0.501 | -5.274 | -9.67 | -16.452 | -27.847 | -38.999 | -32.947 | -34.404 | -22.039 | -21.407 | -22.071 | -19.216 | -50.081 | -12.516 | -10.38 |
| Operating Income Ratio
| -0.018 | -0.215 | -0.003 | -0.01 | -0.098 | -0.206 | -0.458 | -0.811 | -1.738 | -3.912 | -18.378 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -18.576 | -6.439 | -3.733 | -4.906 | -4.953 | -1.831 | 3.044 | 0.023 | 13.177 | -0.699 | -11.292 | 3.083 | 0 | 4.987 | -23.142 | -10.454 | 0.001 | 0.006 |
| Income Before Tax
| -20.047 | -18.079 | -3.934 | -5.407 | -10.227 | -16.277 | -21.838 | -33.002 | -30.515 | -35.736 | -46.229 | -19.746 | 0 | -16.963 | -42.358 | -60.535 | -12.515 | -10.374 |
| Income Before Tax Ratio
| -0.248 | -0.334 | -0.067 | -0.106 | -0.19 | -0.347 | -0.608 | -0.961 | -1.36 | -4.243 | -24.695 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.085 | 0.028 | 0.438 | -0.068 | 0.216 | 0.106 | 0.163 | 0.172 | 0.13 | 0.174 | 0.395 | 0.689 | 0.976 | -8.212 | 25.002 | 11.383 | -6.811 | 2.591 |
| Net Income
| -20.132 | -18.107 | -4.372 | -5.339 | -10.443 | -16.383 | -22.001 | -33.174 | -30.645 | -35.91 | -46.229 | -19.746 | -22.516 | -13.859 | -44.218 | -61.464 | -5.705 | -12.971 |
| Net Income Ratio
| -0.249 | -0.335 | -0.074 | -0.105 | -0.194 | -0.349 | -0.613 | -0.966 | -1.366 | -4.263 | -24.695 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.79 | -2.59 | -0.66 | -1.04 | -2.19 | -3.51 | -4.93 | -9.42 | -10.34 | -13.33 | -21.96 | -9.41 | -10.77 | -9.38 | -437.12 | -569.46 | -52.86 | -120.18 |
| EPS Diluted
| -0.79 | -2.59 | -0.66 | -1.04 | -2.19 | -3.47 | -4.93 | -9.42 | -10.34 | -13.33 | -21.96 | -9.41 | -10.77 | -9.38 | -437.12 | -569.46 | -52.86 | -120.18 |
| EBITDA
| 7.276 | -8.934 | 2.378 | 2.175 | -2.633 | -7.025 | -16.619 | -25.08 | -36.444 | -32.288 | -34.404 | -22.034 | -21.407 | -26.864 | 5.024 | -39.386 | -12.37 | -10.257 |
| EBITDA Ratio
| 0.09 | -0.165 | 0.04 | 0.043 | -0.049 | -0.15 | -0.463 | -0.73 | -1.624 | -3.833 | -18.378 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |